Skip to main content
. Author manuscript; available in PMC: 2011 Oct 15.
Published in final edited form as: Int J Cancer. 2010 Oct 15;127(8):1882–1892. doi: 10.1002/ijc.25199

Table 4.

Hazard ratio* for time-to-clearance between HPV types for clinician-collected lavage samples and self-collected samples

Clinician-collected lavage samples
6 16 18 39 51 52 53 59 62 66 68 84 89
1.89*** 1.43 1.60*** 1.63*** 1.64** 1.80*** 2.28*** 3.15*** 1.22 2.49*** 1.36 1.62** 6
0.70* 0.76 0.85 0.79 0.89 1.06 1.62* 0.66** 1.14 0.66** 0.81 16
1.09 1.25 1.22 1.42 1.68*** 2.48*** 0.85 2.04** 1.03 1.26 18
1.14 1.04 1.20 1.50** 2.20*** 0.80 1.77** 0.90 1.07 39
0.91 0.99 1.21 1.83** 0.76 1.31 0.75* 0.91 51
1.12 1.38 2.04*** 0.78 1.66* 0.87 1.02 52
1.23 1.85** 0.66** 1.52 0.75 0.88 53
1.48 0.55*** 1.14 0.61*** 0.74 59
0.38*** 0.77 0.41*** 0.49*** 62
1.93** 1.08 1.36 66
0.52*** 0.62* 68
1.21 84
89
Self-collected samples
6 16 18 39 51 52 53 59 62 66 68 84 89
1.63** 1.44 0.97 1.38 1.49** 1.44* 1.70*** 2.12*** 1.43 1.57* 0.96 1.28 6
0.83 0.55*** 0.77 0.84 0.78 0.88 1.77 0.76 0.83 0.52*** 0.77 16
0.65* 1.00 1.07 1.00 1.12 1.55 0.92 1.05 0.63** 0.94 18
1.57** 1.62** 1.65*** 1.70** 2.28*** 1.40 1.75** 0.97 1.41* 39
1.13 1.04 1.13 1.60** 0.95 1.07 0.63*** 0.98 51
0.94 1.04 1.38 0.86 0.98 0.59*** 0.90 52
1.08 1.53* 0.86 1.03 0.61*** 0.94 53
1.36 0.81 1.02 0.56*** 0.79 59
0.61* 0.71 0.42*** 0.65* 62
1.23 0.66 0.97 66
0.55 0.90 68
1.46** 84
89
***

p<0.01;

**

p<0.05;

*

p<0.10

*

Hazard ratio is defined as the hazard of HPV types listed in right column compared to HPV listed on top row.